COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 1354: Articles 13531-13540  | Next

Doxycycline inhibition of a pseudotyped virus transduction does not translate to inhibition of SARS-CoV-2 infectivity
Diomede, L., Baroni, S., De Luigi, A., Piotti, A., Lucchetti, J., Fracasso, C., Russo, L., Bonaldo, V., Panini, N., Filippini, F., Fiordaliso, F., Corbelli, A., Beeg, M., Pizzato, M., Caccuri, F., Gobbi, M., Biasini, E., Caruso, A., Salmona, M.
10.1101/2021.07.30.454436 — Posted: 2021-07-30
Highly efficient SARS-CoV-2 infection of human cardiomyocytes: spike protein-mediated cell fusion and its inhibition
Navaratnarajah, C. K., Pease, D. R., Halfmann, P., Taye, B., Barkhymer, A., Howell, K. G., Charlesworth, J. E., Christensen, T. A., Kawaoka, Y., Cattaneo, R., Schneider, J. W., Timothy J. Nelson (Director), Boyd Rasmussen and Frank J. Secreto
10.1101/2021.07.30.454437 — Posted: 2021-07-30
Influence of social determinants of health and county vaccination rates on machine learning models to predict COVID-19 case growth in Tennessee
Wylezinski, L. S., Harris, C. R., Heiser, C. N., Gray, J. D., Spurlock, C. F.
10.1101/2021.07.28.21260814 — Posted: 2021-07-30 Discussion: Offsite
COVID-ONE-humoral immune: The One-stop Database for COVID-19-specific Antibody Responses and Clinical Parameters
Xu, Z., Li, Y., Lei, Q., Huang, L., Lai, D.-y., Guo, S.-j., Jiang, H.-w., Hou, H., Zheng, Y.-x., Wang, X.-n., Wu, J., Ma, M.-l., Zhang, B., Chen, H., Yu, C., Xue, J.-b., Zhang, H.-n., Qi, H., Yu, S., Lin, M., Zhang, Y., Lin, X., Yao, Z., Sheng, H., Sun, Z., Wang, F., Fan, X., Tao, S.-c.
10.1101/2021.07.29.454261 — Posted: 2021-07-30
SARS-CoV-2 introduction and lineage dynamics across three epidemic peaks in Southern Brazil: massive spread of P.1
Varela, A. P. M., Prichula, J., Meyer, F. Q., Salvato, R., Sant'Anna, F. H., Gregianini, T. S., Martins, L. G., Seixas, A., Veiga, A. B. G. d.
10.1101/2021.07.29.454323 — Posted: 2021-07-30
Identification and Characterization of novel mutants of Nsp13 Protein among Indian SARS-CoV-2 isolates.
Kumari, D., Kumari, N., Kumar, S., Sinha, P. K., Shahi, S. K., Biswas, N. R., Kumar, A.
10.1101/2021.07.30.454406 — Posted: 2021-07-30
3D printed cobalt-chromium-molybdenum porous superalloy with superior antiviral activity
Arjunan, A., Robinson, J., Baroutaji, A., Marti, M., Tunon-Molina, A., Serrano-Aroca, A.
10.1101/2021.07.29.454385 — Posted: 2021-07-30
Diagnostic performance of a novel digital immunoassay (RapidTesta SARS-CoV-2): a prospective observational study with 1,127 nasopharyngeal samples
Suzuki, H., Akashi, Y., Ueda, A., Kiyasu, Y., Takeuchi, Y., Maehara, Y., Ochiai, Y., Okuyama, S., Notake, S., Nakamura, K., Ishikawa, H.
10.1101/2021.07.26.21261162 — Posted: 2021-07-30
Can Vaccine Prioritization Reduce Disparities in Covid-19 Burden for Historically Marginalized Populations?
Rosenstrom, E., Mele, J. A., Ivy, J., Mayorga, M., Patel, M., Hassmiller Lich, K., Johnson, K. D., Delamater, P., Keskinocak, P., Boyce, R., Smith, R., Swann, J. L.
10.1101/2021.07.27.21261210 — Posted: 2021-07-30
A method for the generation of pseudotyped virus particles bearing SARS coronavirus spike protein in high yields
Fujioka, Y., Kashiwagi, S., Yoshida, A., Satoh, A. O., Fujioka, M., Amano, M., Yamauchi, Y., Ohba, Y.
10.1101/2021.07.30.454063 — Posted: 2021-07-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).